Why the study?
Does urinary adiponectin excretion indicate vascular damage and increased risk for vascular events?
Does urinary adiponectin excretion indicate vascular damage and increased risk for vascular events?
Answers are grounded in this paper and cite their sources.
Urinary adiponectin excretion may serve as a biomarker for vascular damage and future vascular events.
Quantification of urinary adiponectin excretion appears to be an independent indicator of vascular damage potentially identifying an increased risk for vascular events.
No takes yet. Share an insight, caveat, or question.
Eynatten et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: